
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 5.68 | 5.94 | 0.26 |
Shares | 94.32 | 94.32 | 0.00 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 10.20 | 11.64 |
Price to Book | 1.34 | 1.40 |
Price to Sales | 0.68 | 0.99 |
Price to Cash Flow | 6.80 | 6.34 |
Dividend Yield | 3.34 | 4.00 |
5 Years Earnings Growth | 8.65 | 9.71 |
Name | Net % | Category Average |
---|---|---|
Industrials | 29.12 | 14.63 |
Consumer Cyclical | 15.07 | 10.61 |
Healthcare | 12.89 | 10.62 |
Basic Materials | 12.56 | 7.24 |
Consumer Defensive | 11.18 | 9.50 |
Technology | 7.51 | 8.53 |
Financial Services | 6.36 | 22.40 |
Energy | 3.31 | 6.66 |
Communication Services | 1.72 | 6.06 |
Real Estate | 0.28 | 1.81 |
Number of long holdings: 88
Number of short holdings: 3
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
J&J | US4781601046 | 3.69 | 154.16 | -0.04% | |
Safran | FR0000073272 | 3.08 | 250.30 | +0.85% | |
Deutsche Post | DE0005552004 | 2.90 | 39.040 | +4.75% | |
Kemira Oyj | FI0009004824 | 2.83 | 19.28 | +3.16% | |
CNH Industrial NV | NL0010545661 | 2.75 | 13.30 | +4.15% | |
FMC | US3024913036 | 2.75 | 38.22 | +3.89% | |
Roche Holding Participation | CH0012032048 | 2.57 | 261.90 | +1.67% | |
UOB | SG1M31001969 | 2.52 | 34.83 | +0.81% | |
Winpak | CA97535P1045 | 2.50 | 43.23 | +0.68% | |
Diageo | GB0002374006 | 2.50 | 2,177.0 | -0.09% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Tweedy, Browne Global Value | 4.45B | 8.57 | 7.17 | 4.92 | ||
Tweedy, Browne Value | 415.75M | 5.70 | 7.35 | 5.40 | ||
Tweedy, Browne Worldwide Hi Div Yld | 61.24M | 3.95 | 3.62 | 3.68 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review